Search
Nitroxoline
go.drugbank.com/drugs/DB01422ExperimentalNitroxoline is a urinary antibacterial agent active against susceptible gram-positive and gram-negative organisms commonly found in urinary tract infections.
Prezatide copper
go.drugbank.com/drugs/DB14683InvestigationalPrezatide is used in cosmetic products for the skin and hair. … It is known to aid wound healing and its potential applications in chronic obstructive pulmonary disease and metastatic colon cancer are currently being investigated.
XL844
go.drugbank.com/drugs/DB05149InvestigationalXL844 is a potent inhibitor of the checkpoint kinases CHK1 and CHK2, which induce cell cycle arrest in response to a variety of DNA damaging agents.
Terevalefim
go.drugbank.com/drugs/DB16397InvestigationalTerevalefim is under investigation in clinical trial NCT02474667 (Reduce the Severity of DGF in Recipients of a Deceased Donor Kidney).
Acifluorfen
go.drugbank.com/drugs/DB07338ExperimentalAcifluorfen is a protoporphyrinogen oxidase inhibitor.
Categories: Compounds used in a research, industrial, or household settingSulfobutylether-beta-cyclodextrin
go.drugbank.com/drugs/DB18607ExperimentalCategories: Compounds used in a research, industrial, or household setting4-Nitrophenyl Phosphate
go.drugbank.com/drugs/DB04214ExperimentalCategories: Compounds used in a research, industrial, or household settingEgtazic acid
go.drugbank.com/drugs/DB19986ExperimentalEgtazic acid is a small molecule drug. Egtazic acid has a monoisotopic molecular weight of 380.14 Da.
Categories: Compounds used in a research, industrial, or household settingDenopamine
go.drugbank.com/drugs/DB21277ExperimentalDenopamine is a small molecule drug. Denopamine has a monoisotopic molecular weight of 317.16 Da.
Categories: Compounds used in a research, industrial, or household settingBlonanserin
go.drugbank.com/drugs/DB09223InvestigationalBlonanserin is an atypical antipsychotic approved in Japan in January, 2008. … As a second-generation (atypical) antipsychotic, it is significantly more efficacious in the treatment of the negative symptoms of schizophrenia compared to first-generation (typical) antipsychotics.